No clinically significant pharmacokinetic interactions between dolutegravir and daclatasvir in healthy adult subjects
Crossref DOI link: https://doi.org/10.1186/s12879-016-1629-5
Published Online: 2016-07-22
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ross, Lisa L.
Song, Ivy H.
Arya, Niki
Choukour, Mike
Zong, Jian
Huang, Shu-Pang
Eley, Timothy
Wynne, Brian
Buchanan, Ann M.
Funding for this research was provided by:
ViiV Healthcare
License valid from 2016-07-22